Watch New Video
Learn
How LRF
Can Help
You
Stories of Hope
"I want to be
very involved
with helping
others cope
with this disease."
Download the latest issue of Lymphoma Today
Order free Booklets and Fact Sheets about Hodgkin and Non-Hodgkin Lymphoma
Order your free copies of Research in Focus today.
What you need to know
About Lymphoma 
Whether you or someone you love is newly diagnosed or a long-term survivor, Lymphoma Research Foundation (LRF) is here to help you. On this website, you will find up-to-date information on the many subtypes of two closely related cancers that affect the lymphatic system- Hodgkin lymphoma and non-Hodgkin lymphoma. Teleconferences, webcasts/podcasts and written material provide you with information developed specifically for patients and loved ones by leading lymphoma experts. LRF provides in-person patient education programs around the country, offers comprehensive patient support and clinical trials services and funds lymphoma research.
Lymphoma Survivor & Singing Sensation – Barbara Padilla’s Story of Hope
"My lump was about the size of a lime cut in half and was not symmetrical. I could not see it, but I could feel it. If you notice a lump that will not go away; go see your doctor."
Foundation News: Programs, Research & Advocacy
Update on Lymphoma Treatment Options from the American Society of Hematology Annual Meeting
Register today for a free teleconference on Tuesday, December 15, 2009.
Lymphoma Research Foundation Announces Recipients of CLL/SLL Research Initiative Grants
Second round of funding awarded to David Frank, MD, PhD -- Dana-Farber Cancer Institute and Thomas Kipps, MD, PhD -- Moores Cancer Center , University of California , San Diego.
President's Cancer Panel Announces Public Meetings
The President's Cancer Panel is holding a series of meetings pertaining to cultural and demographic factors in cancer research.
Check out what has been happening in Houston, NYC, Long Island, Minnesota, Chicago and Arizona
Click for more Foundation News
Lymphoma in the News:
New Cutaneous T-cell Lymphoma Treatment Romidepsin Approved by FDA
The FDA recently approved the use of romidepsin (Istodax) for treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic, or whole body, treatment.
New Monoclonal Antibody Approved for the Treatment of Refractory CLL
FDA grants the accelerated approval of ofatumomab (Arzerra) for the treatment of patients with chronic lymphocytic leukemia (CLL) whose disease is refractory to fludarabine (Fludara) and alemtuzumab (Campath).
FDA Approves New Therapy
U.S. Food and Drug Administration approves first therapy for patients with relapsed or refractory peripheral T-cell lymphoma.
Click for more Lymphoma in the News
How You Can Make A Difference!
Join Team LRF for Lymphoma Research Foundation
Combine your enthusiasm for endurance sporting events with your dedication to raise awareness and funds for LRF!
Take a Step and Find a Cure for Lymphoma by participating in one of our 16 Lymphomathons nationwide
Stay Connected –
Follow us on 
Become a fan on 
Click for more Make A Difference
